Deuterated protease inhibitors

Loading...
Thumbnail Image
Authors
Chang, Kyeong-Ok
Kim, Yunjeong
Groutas, William C.
Perlman, Stanley
Advisors
Issue Date
2021-12-09
Type
Patent
Keywords
Research Projects
Organizational Units
Journal Issue
Citation
Chang, K., Kim, Y., Groutas, W.C., Perlman, S., inventors; Kansas State University Research Foundation (Manhattan, KS), Wichita State University, University of Iowa Research Foundation (Iowa City, IA), assignee. Deuterated protease inhibitors. United States patent US 20210380531 A1. 2021, December 9.
Abstract

Compounds and treatment methods with compounds exhibiting antiviral activity and/or inhibition of viral replication against viruses, particularly those belonging to the picornavirus-like supercluster, including coronavirus having a formula: ##STR00001## or a prodrug or pharmaceutically-acceptable salt thereof, where: each X comprises at least one cyclic moiety directly attached to the oxygen or connected via an alkyl linkage, where at least one of the linkage and/or the X moiety comprises a deuterium substitution; and Z is selected from the group consisting of aldehydes and bisulfite salts, or the ester or carbamate prodrugs thereof.

Table of Contents
Description
WSU inventor: Groutas, William C., Dept. of Chemistry, College of Liberal Arts and Sciences
Application No: 17/343334 filed June 9, 2021. Patent No: US 20210380531 A1 granted December 9, 2021.
Publisher
United States Patent and Trademark Office
Journal
Book Title
Series
PubMed ID
DOI
ISSN
EISSN